灵灵九生物|化工原料平台|009

主页 > 生物化工 > 生化试剂 >

DEBIO 0932

中文名称:
DEBIO 0932
中文同义词:
HSP90抑制剂(DEBIO 0932)
英文名称:
Debio 0932 ,CUDC-305
英文同义词:
Debio 0932;Debio 0932 ,CUDC-305;CUDC-305 (DEBIO-0932 );CUDC-305;CS-1423;1H-Imidazo[4,5-c]pyridine-1-ethanamine, 4-amino-2-[[6-(dimethylamino)-1,3-benzodioxol-5-yl]thio]-N-(2,2-dimethylpropyl)-
CAS号:
1061318-81-7
分子式:
C22H30N6O2S
分子量:
442.58
EINECS号:
相关类别:
细胞生物学试剂
Mol文件:
1061318-81-7.mol
沸点 
654.8±65.0 °C(Predicted)
密度 
1.32±0.1 g/cm3(Predicted)
酸度系数(pKa)
10.02±0.19(Predicted)
用途 
一种HSP90(热休克蛋白90)抑制剂,对 HSP90α和 HSP90β的IC50值分别为100和103nM。Debio 0932 is a novel heat shock protein 90 (HSP90) inhibitor with strong affinity for HSP90 alpha/beta, high oral bioavailability and potent anti-proliferative activity against a broad range of cancer cell lines (with a mean IC50 of 220 nmol/L), including many non-small cell lung cancer (NSCLC) cell lines which are resistant to standard-of-care (SOC) agents. Debio 0932 potently inhibits tumour growth in subcutaneous xenograft models of a number of solid and haematological malignancies, including models of NSCLC which harbour mutations conferring acquired or primary erlotinib resistance.
价       格:请咨询卖家
CAS    号: 1061318-81-7
规       格:10g/20g/100g/1kg
咨询电话:15623309010
正品保障
正规发票
闪电发货
满199包邮
详细介绍
英文名:
Debio 0932 ,CUDC-305
外观:
纯度:
请咨询卖家
分子式:
C22H30N6O2S
分子量:
442.58
中文名称:
DEBIO 0932
中文同义词:
HSP90抑制剂(DEBIO 0932)
英文名称:
Debio 0932 ,CUDC-305
英文同义词:
Debio 0932;Debio 0932 ,CUDC-305;CUDC-305 (DEBIO-0932 );CUDC-305;CS-1423;1H-Imidazo[4,5-c]pyridine-1-ethanamine, 4-amino-2-[[6-(dimethylamino)-1,3-benzodioxol-5-yl]thio]-N-(2,2-dimethylpropyl)-
CAS号:
1061318-81-7
分子式:
C22H30N6O2S
分子量:
442.58
EINECS号:
相关类别:
细胞生物学试剂
Mol文件:
1061318-81-7.mol
沸点 
654.8±65.0 °C(Predicted)
密度 
1.32±0.1 g/cm3(Predicted)
酸度系数(pKa)
10.02±0.19(Predicted)
用途 
一种HSP90(热休克蛋白90)抑制剂,对 HSP90α和 HSP90β的IC50值分别为100和103nM。Debio 0932 is a novel heat shock protein 90 (HSP90) inhibitor with strong affinity for HSP90 alpha/beta, high oral bioavailability and potent anti-proliferative activity against a broad range of cancer cell lines (with a mean IC50 of 220 nmol/L), including many non-small cell lung cancer (NSCLC) cell lines which are resistant to standard-of-care (SOC) agents. Debio 0932 potently inhibits tumour growth in subcutaneous xenograft models of a number of solid and haematological malignancies, including models of NSCLC which harbour mutations conferring acquired or primary erlotinib resistance.
优质服务
客服电话 1562309010
正品保障 正品保障  提供发票
急速物流 现货闪电  当时发货
售后无忧 不满意退货